Medical Oncologist
2005, Master of Science, Clinical Trials Design and Statistical Analysis, University of Michigan, Ann Arbor, Michigan
1999, Doctor of Medicine, University of Texas Health Sciences Center at Houston, Texas
Recognizing that each patient has a unique story, Joanne Jeter, M.D., strives to have a positive impact on that story as an expert in clinical cancer genomics. She relishes the chance to help patients manage their genetic risk, educating them about their options so they can make more informed decisions and influencing how their family members approach their own cancer risk.
Named a fellow of the American Society of Clinical Oncology (ASCO) shortly before joining City of Hope® in 2023, Dr. Jeter is a seasoned clinical researcher with a many peer-reviewed scientific publications to her name. Her investigations have been funded by the National Cancer Institute, SWOG (formerly the Southwest Oncology Group) and ASCO. Dr. Jeter has given invited lectures internationally on oncology, end-of-life care and cancer genetics. Before joining City of Hope, she held faculty appointments at the University of Utah, Ohio State University and the University of Arizona.
She was drawn to City of Hope for its reputation for groundbreaking cancer care. "As I saw more and more of my respected colleagues gravitate to the program at City of Hope and heard about the leading-edge work they strive to do,†she says, “I knew I wanted to be a part of it.â€